Drug Pricing

Washington – The White House has announced a fresh agreement with several major pharmaceutical manufacturers that aims to reshape the way prescription drugs are priced in the United States. While the pact covers a broad spectrum of medications, its most immediate impact is expected to be felt by patients who...

The Trump administration is contemplating a regulatory move that could force pharmaceutical companies to lower US drug prices to match those in other wealthy countries, according to a notice posted on a federal website. The proposed rule, referred to as the "global benchmark for efficient drug pricing (GLOBE) model," aims...